KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $267,000 | – | 70,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 25,791,678 | $170,741,000 | 2.32% |
| Abrams Capital Management | 5,719,176 | $37,861,000 | 1.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 562,900 | $3,726,000 | 0.97% |
| Old West Investment Management, LLC | 126,230 | $835,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 450,111 | $2,980,000 | 0.53% |
| Virtus ETF Advisers LLC | 92,536 | $613,000 | 0.46% |
| Knoll Capital Management, LLC | 200,000 | $1,324,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 912,830 | $6,043,000 | 0.35% |
| CLOUGH CAPITAL PARTNERS L P | 879,900 | $5,825,000 | 0.31% |
| Century Capital Management, LLC | 272,773 | $1,806,000 | 0.20% |